Hepatitis B and hepatitis C are leading causes of cirrhosis and liver cancer and caused 1.3 million deaths worldwide in 2022. Hepatitis B is preventable with vaccination, and hepatitis C is curable with direct-acting antivirals. In 2015, in collaboration with CDC and other partners, Georgia, a country at the intersection of Europe and Asia, launched a hepatitis C elimination program to reduce the prevalence of chronic hepatitis C; at that time, the prevalence was 5.4%, more than five times the global average of 1.0%. In 2016, the World Health Assembly endorsed a goal for the elimination of viral hepatitis as a public health problem by 2030. In 2024, 89% of the Georgian adult population have received screening for hepatitis C, 83% of persons with current chronic HCV infection have received a diagnosis, and 86% of those with diagnosed hepatitis C have started treatment. During 2015-2023, vaccination coverage with the hepatitis B birth dose and with 3 doses of hepatitis B vaccine among infants exceeded 90% for most years. In 2021, the prevalence of hepatitis B surface antigen was 0.03% among children and adolescents aged 5-17 years and 2.7% among adults. Georgia has demonstrated substantial progress toward hepatitis B and hepatitis C elimination. Using lessons from the hepatitis C elimination program, scale-up of screening and treatment for hepatitis B among adults would prevent further viral hepatitis-associated morbidity and mortality in Georgia and would accelerate progress toward hepatitis B and hepatitis C elimination by 2030.

中文翻译：

---

2015 年 4 月至 2024 年 4 月，格鲁吉亚消除乙型肝炎和丙型肝炎的进展。


乙型肝炎和丙型肝炎是肝硬化和肝癌的主要原因，到 2022 年，它们会导致全球 130 万人死亡。乙型肝炎可以通过疫苗接种来预防，丙型肝炎可以通过直接作用的抗病毒药物治愈。 2015年，位于欧洲和亚洲交汇处的格鲁吉亚与CDC和其他合作伙伴合作，启动了丙型肝炎消除计划，以降低慢性丙型肝炎的患病率；当时，患病率为 5.4%，是全球平均水平 1.0% 的五倍多。 2016年，世界卫生大会批准了到2030年消除病毒性肝炎这一公共卫生问题的目标。到2024年，89%的格鲁吉亚成年人接受了丙型肝炎筛查，83%的当前患有慢性丙型肝炎病毒感染的人接受了丙型肝炎筛查已得到诊断，86% 的丙型肝炎确诊患者已开始治疗。 2015年至2023年，婴儿乙型肝炎出生剂量和3剂乙型肝炎疫苗接种率多数年份超过90%。 2021年，5-17岁儿童青少年乙型肝炎表面抗原患病率为0.03%，成人乙型肝炎表面抗原患病率为2.7%。格鲁吉亚在消除乙型肝炎和丙型肝炎方面取得了实质性进展。利用消除丙型肝炎计划的经验教训，扩大成人乙型肝炎的筛查和治疗范围将进一步防止格鲁吉亚与病毒性肝炎相关的发病率和死亡率的上升，并将加速到 2030 年消除乙型肝炎和丙型肝炎的进程。